BioMed Research International / 2021 / Article / Tab 3 / Research Article
Initial Results of Tests Using GSR Biofeedback as a New Neurorehabilitation Technology Complementing Pharmacological Treatment of Patients with Schizophrenia Table 3 Therapy effects and the type of change that occurred in the studied group by training module.
Patient: CODE Change type CENTER BALANCE INSECTS Number of measurements % Number of measurements % Number of measurements % BF-2 (12 measurements) Relaxation (increase in value) 7 58.33 3 25.00 1 8.33 No change in value 0 0.00 0 0.00 1 8.33 Activation (decrease in value) 5 41.67 9 75.00 10 83.33 BF-3 (12 measurements) Relaxation (increase in value) 7 58.33 3 25.00 9 75.00 Activation (decrease in value) 5 41.67 9 75.00 3 25.00 BF-7 (12 measurements) Relaxation (increase in value) 11 91.67 12 100.00 10 83.33 Activation (decrease in value) 1 8.33 0 0.00 2 16.67 BF-8 (12 measurements) Relaxation (increase in value) 10 83.33 7 58.33 4 33.33 Activation (decrease in value) 2 16.67 5 41.67 8 66.67 BF-9 (12 measurements) Relaxation (increase in value) 8 66.67 1 8.33 3 25.00 Activation (decrease in value) 4 33.33 11 91.67 9 75.00 BF-10 (12 measurements) Relaxation (increase in value) 8 66.67 7 58.33 5 41.67 Activation (decrease in value) 4 33.33 5 41.67 7 58.33 Total (72 measurements) Relaxation (increase in value) 51 70.83 33 45.83 32 44.44 No change in value 0 0.00 0 0.00 1 1.39 Activation (decrease in value) 21 29.17 39 54.17 39 54.17